1 in 4 Covered California Enrollees Could Get State Aid Under Newsom Proposal
0:00 0:00 Produced in partnership with: Embed Download Volume Speed 0.5x 1x 1.25x 1.5x 2x Embed this player × Copy When Congress allowed covid-era subsidies
another news portal
0:00 0:00 Produced in partnership with: Embed Download Volume Speed 0.5x 1x 1.25x 1.5x 2x Embed this player × Copy When Congress allowed covid-era subsidies
Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have discovered a new strategy that may protect neurons and other brain cells involved
Researchers at Kanazawa University have identified a previously unrecognized mechanism by which structural changes in the cerebellum influence social behavior.
A research team at the University of Zurich (UZH) has discovered biomarkers of sleep loss in saliva. Acute sleep deprivation can be detected using just
A joint study by the University of Oulu and Oulu University Hospital suggests that a newborn’s upper lip frenulum is unlikely to be a major
A comprehensive review led by Associate Researcher Linnan Zhu and Academician Zemin Zhang at Biomedical Pioneering Innovation Center (BIOPIC), Peking University, China, and Chongqing Medical
Children can test the new miniature replica of an MRI machine on different toys.
The aim of the Hele Road ward is to give students hands-on experience with equipment and patients.
Patients have been urged to only attend A&E if their condition is life-threatening or serious.
Only select groups of teenagers and some young people will be eligible for the vaccine. Here’s why.
It was a mistake to treat bad faith political actors as wise medical sages. Cildren are paying the price today. The post MAHA Doctors Promised
Persistent symptoms after COVID-19 infection continue to affect millions of people worldwide, even as the number of acute infections has declined.
There are few treatment options available for people with disorders of the esophagus. Delivering drugs directly to this part of the body is difficult, so
PhoreMost Limited, a biotech company focused on turning scientific breakthroughs into life-changing cancer drugs, today announced its lead program, PMC-001, a next-generation, small molecule microtubule